Postoperative outcomes of intrasphincteric botox injection during hemorrhoidectomy: A double-blind clinical trial

(2021) Postoperative outcomes of intrasphincteric botox injection during hemorrhoidectomy: A double-blind clinical trial. JOURNAL OF RESEARCH IN MEDICAL SCIENCES. ISSN 1735-1995 1735-7136 J9 - J RES MED SCI

Full text not available from this repository.

Abstract

Background: Pain is the most common postoperative complication of hemorrhoidectomy. We evaluated the effectiveness of intrasphincteric Botox injection on posthemorrhoidectomy complications including pain reduction and wound healing. Materials and Methods: In this randomized, double-blind clinical trial, patients with Grades 3 or 4 symptomatic hemorrhoids who underwent open (Milligan-Morgan) hemorrhoidectomy were enrolled. The experimental group received intrasphincteric Botox injection during hemorrhoidectomy, while the controls received normal saline injection. Hemorrhoid grades, constipation status, history of hemorrhoidectomy, duration of operation, pain at rest and after defecation in six follow-up periods (6, 12, 24, and 48 h and 7 and 14 days after operation), wound healing (during follow-up after discharge with a 2-week period), analgesic use, and Botox side effects were evaluated and compared in the two experimental and control groups. Results: In this trial, 34 and 33 patients were randomly allocated in the experimental and control groups, respectively. Operation time was significantly higher in Botox group (P = 0.009). Mean dose of analgesics use in Botox was significantly lower (P < 0.001). Rate of wound healing during follow-ups was significantly higher in Botox group in the fifth follow-up (P = 0.009). Frequency of urinary retention (P = 0.02) and moderate itching (P = 0.01) was significantly higher in placebo than Botox group. Mean of postoperative pain at rest in Botox group was significantly lower at 12th, 24th, and 48th h and 7th and 14th days after operation (P < 0.01). Mean of postoperative pain in Botox group was significantly lower at 3rd to 5th defecation (P < 0.01). Conclusion: Our findings indicated that a single-dose injection of Botox during Milligan-Morgan hemorrhoidectomy is associated with less postsurgical pain at rest and during defecation and improved wound healing. It is suggested that it is a safe and effective procedure during hemorrhoidectomy regarding the procedure-related complications.

Item Type: Article
Keywords: Botox Botulinum toxin hemorrhoidectomy pain MILLIGAN-MORGAN HEMORRHOIDECTOMY GLYCERYL TRINITRATE OINTMENT PAIN-CONTROL BOTULINUM MULTICENTER
Journal or Publication Title: JOURNAL OF RESEARCH IN MEDICAL SCIENCES
Journal Index: ISI
Volume: 26
Number: 1
Identification Number: https://doi.org/10.4103/jrms.JRMS₆₁₂₁₈
ISSN: 1735-1995 1735-7136 J9 - J RES MED SCI
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/17338

Actions (login required)

View Item View Item